Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
Join a leading global organization as a Scientific Associate at Charles River Laboratories. In this 12-month fixed-term contract role, work in our Clinical Pathology Laboratory, operating automated systems, analyzing samples, and developing innovative techniques. Bring your organizational and IT skills to make a difference in improving lives.
Social network you want to login/join with:
At Charles River, we are passionate about improving the quality of people’s lives. When you join our global family, you will help create healthier lives for millions of patients and their families.
Charles River employees are innovative thinkers, who are dedicated to continuous learning and improvement. We will empower you with the resources you need to grow and develop in your career.
As a Charles River employee, you will be part of an industry-leading, customer-focused company at the forefront of drug development. Your skills will play a key role in bringing life-saving therapies to market faster through simpler, quicker, and more digitalized processes. Whether you are in lab operations, finance, IT, sales, or another area, when you work at Charles River, you will be the difference every day for patients across the globe.
We are seeking a Scientific Associate for ourClinical Pathology Laboratory departmentsite located in Elphinstone, Tranent. This is a 12 month fixed term contract opportunity.
About Clinical Pathology Laboratory Services
Clinical Pathology is responsible for analysing biological samples, mostly blood and urine, taken from animals on toxicology and other regulatory studies. Training will be provided for instrument operation, use of our Laboratory Information Management System and working in a GLP environment.
Key responsibilities include the following:
The following are minimum requirements related to the Scientific Associate position:
The closing date is 16 July 2025.
Salary for this position is £27,951.22 per annum.
About Corporate Functions
The Corporate Functions provide operational support across Charles River in areas such as Human Resources, Finance, IT, Legal, Sales, Quality Assurance, Marketing, and Corporate Development. They partner with their colleagues across the company to develop and drive strategies and to set global standards. The functions are essential to providing a bridge between strategic vision and operational readiness, to ensure ongoing functional innovation and capability improvement.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.
For more information, please visit www.criver.com.